b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29844307</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>10</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>17</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2041-4889</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>9</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>05</Month>\n                        <Day>29</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cell death &amp; disease</Title>\n                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>640</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-018-0698-3</ELocationID>\n            <Abstract>\n                <AbstractText>Although evidence has emerged to suggest that YAP overexpression is a crucial factor for tumor progression and resistance to targeted drugs in multiple cancers, the miRNA-mediated YAP regulation is still unclear. Here we show that the novel miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP. Our data showed that the miR-550a-3-5p suppressed cell proliferation, metastasis, and tumor sphere formation through the direct inhibition of YAP and its oncogenic pathway in various cancer cell types. In addition, we showed that the YAP signature was associated with poor survival of colon cancer and identified an inverse correlation between miR-550a-3-5p and YAP in colon cancer tissues. Interestingly, this inverse correlation was regulated in a density-dependent manner. Furthermore, high levels of miR-550a-3-5p were associated with a good prognosis of esophageal cancer, which was suggestive of the clinical relevance of miR-550a-3-5p-mediated YAP regulation in multiple cancers. Importantly, we demonstrated that miR-550a-3-5p treatment sensitized vemurafenib-resistant colon and melanoma cells through YAP inhibition with reduced AKT activity. Moreover, the tumor-suppressive activity of miR-550a-3-5p and its sensitization effect for vemurafenib resistance were also observed in tumor xenograft models. Collectively, our data suggest that miR-550a-3-5p acts as a tumor suppressor through the targeting of oncogenic YAP and may be a new therapeutic tool for YAP-mediated BRAF inhibitor resistance in BRAF-mutant cancer cells.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Choe</LastName>\n                    <ForeName>Min Ho</ForeName>\n                    <Initials>MH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Biochemistry, Division of Life Sciences, Korea University, Seoul, 02841, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yoon</LastName>\n                    <ForeName>Yina</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Joon</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Biochemistry, Division of Life Sciences, Korea University, Seoul, 02841, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hwang</LastName>\n                    <ForeName>Sang-Gu</ForeName>\n                    <Initials>SG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Han</LastName>\n                    <ForeName>Young-Hoon</ForeName>\n                    <Initials>YH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea. yhhan@kirams.re.kr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Jae-Sung</ForeName>\n                    <Initials>JS</Initials>\n                    <Identifier Source="ORCID">0000-0002-8017-4515</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea. jaesung@kirams.re.kr.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon, Korea. jaesung@kirams.re.kr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>29</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Cell Death Dis</MedlineTA>\n            <NlmUniqueID>101524092</NlmUniqueID>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000613721">MIRN550 microRNA, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C088374">YAP1 (Yes-associated) protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019008" MajorTopicYN="Y">Drug Resistance, Neoplasm</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D048493" MajorTopicYN="N">Proto-Oncogene Proteins B-raf</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018874" MajorTopicYN="N">Spheroids, Cellular</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>02</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29844307</ArticleId>\n            <ArticleId IdType="doi">10.1038/s41419-018-0698-3</ArticleId>\n            <ArticleId IdType="pii">10.1038/s41419-018-0698-3</ArticleId>\n            <ArticleId IdType="pmc">PMC5974323</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer Discov. 2012 Mar;2(3):227-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22448344</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2014 Feb 27;156(5):893-906</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24581491</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Biochem Funct. 2015 Jul;33(5):326-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26096363</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Apr 20;6(11):8676-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25895125</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2013 Nov 15;73(22):6667-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23983103</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2009 Dec 8;16(6):498-509</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19962668</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Bioinforma. 2013 Oct 28;3(1):22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24165311</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Physiol Biochem. 2015;37(1):342-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26316081</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2015 Jun;15(6):321-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25998712</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Aug 16;7(33):53853-53868</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27462780</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Mol Med. 2014 Aug;20(8):460-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25027972</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2015 Feb;15(2):73-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25592648</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2014 Jul 3;158(1):185-197</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24954535</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Transl Med. 2015 Dec;3(21):332</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26734642</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gastroenterology. 2010 Mar;138(3):958-68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19914252</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>EMBO J. 2016 Mar 1;35(5):462-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26668268</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Aug 16;7(33):53558-53570</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27448964</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Genet. 2015 Mar;47(3):250-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25665005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2017 Jul 28;399:53-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28433598</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2011 Dec 11;18(1):74-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22157681</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2011 Dec 1;71(23):7137-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22131348</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Pharmacol Sin. 2014 Sep;35(9):1207-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25087998</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochim Biophys Acta. 2016 Oct;1862(10):1926-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27475256</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2013 Feb 1;19(3):657-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23251002</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Cell Biol. 2012 Dec;14 (12 ):1322-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23143395</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2014 Aug 1;350(1-2):34-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24769072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2011 Jun 08;474(7350):179-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21654799</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2009 Dec 15;15(24):7642-7651</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19996206</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2014 Aug 1;74(15):4170-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24906622</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2013 Apr;13(4):246-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23467301</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pigment Cell Melanoma Res. 2017 May;30(3):328-338</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28140520</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2012 Feb 1;72 (3):779-89</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22180495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W460-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25977294</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Mol Life Sci. 2017 Apr;74(8):1457-1474</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27826640</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2010 Apr 9;394(3):623-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20226166</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'